Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Regenerex Pharma Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Regenerex Pharma Inc (RGPX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2025

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/RGPX/competitors                    

                        https://api.csimarket.com/api/v1/companies/RGPX/relationships                    

                        https://api.csimarket.com/api/v1/companies/RGPX/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

RGPX Stock Performance relative to its Competitors

RGPX Competitors (weighted) Percent change over the selected range

Regenerex Pharma Inc's Comment on Competition and Industry Peers

Regenerex develops wound closure system technology and wound care products. Its proprietary Wound Closure System utilizes advanced biotechnology to create an optimal healing environment by addressing chronic, non-healing wounds through protease down-regulation and comprehensive wound bed preparation. The company’s QBx™ platform is designed to treat chronic, non-healing wounds and differs from conventional wound dressings like hydrocolloids and collagens, which primarily absorb wound fluids.

Competitor data is not yet available for Regenerex Pharma Inc.